2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Pericementitis

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Pericementitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, JM; Kwon, KB; Lee, YR; Noh, EM; Song, HK; You, YO	1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Pericementitis

Article	Year
Reversine inhibits MMP-3, IL-6 and IL-8 expression through suppression of ROS and JNK/AP-1 activation in interleukin-1β-stimulated human gingival fibroblasts. Archives of oral biology, 2019, Volume: 108 Topics: Fibroblasts; Gingiva; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; MAP Kinase Kinase 4; Matrix Metalloproteinase 3; Morpholines; NF-kappa B; Periodontitis; Purines; Reactive Oxygen Species; Transcription Factor AP-1	2019

Article

Year

Reversine inhibits MMP-3, IL-6 and IL-8 expression through suppression of ROS and JNK/AP-1 activation in interleukin-1β-stimulated human gingival fibroblasts.

Archives of oral biology, 2019, Volume: 108

Topics: Fibroblasts; Gingiva; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; MAP Kinase Kinase 4; Matrix Metalloproteinase 3; Morpholines; NF-kappa B; Periodontitis; Purines; Reactive Oxygen Species; Transcription Factor AP-1

2019